Showing results (1961-1970 of 19,505) with videos related to

Sort By:
Pageof 1,951
Frontiers in Endocrinology|March 21, 2022
In Vivo Clearance of Apoptotic Debris From Tumor Xenografts Exposed to Chemically Modified Tetrac: Is There a Role for Thyroid Hormone Analogues in Efferocytosis?Kavitha Godugu, Shaker A Mousa, Gennadi V Glinsky, et al.
Frontiers in Endocrinology|March 23, 2022
Neuropsychological Outcomes in Individuals With Type 1 and Type 2 DiabetesNathaniel M Putnam, Evan L Reynolds, Mousumi Banerjee, et al.
Frontiers in Endocrinology|March 28, 2022
miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes MellitusIlona Juchnicka, Mariusz Kuźmicki, Magdalena Niemira, et al.
Frontiers in Endocrinology|April 4, 2022
Case Report: Hypoglycemia Due to a Novel Activating Glucokinase Variant in an Adult - a Molecular ApproachAnojian Koneshamoorthy, Dilan Seniveratne-Epa, Genevieve Calder, et al.
Frontiers in Endocrinology|April 4, 2022
Characterizing and Evaluating Diurnal Salivary Uric Acid Across Pregnancy Among Healthy WomenJenna L Riis, Stephanie H Cook, Nicole Letourneau, et al.
Frontiers in Endocrinology|April 4, 2022
The Long-Term Effects of Non-Pharmacological Interventions on Diabetes and Chronic Complication Outcomes in Patients With Hyperglycemia: A Systematic Review and Meta-AnalysisRongrong Zhou, Yashan Cui, Yuehong Zhang, et al.
Frontiers in Endocrinology|April 4, 2022
Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell ReplacementXin-Xing Wan, Dan-Yi Zhang, Md Asaduzzaman Khan, et al.
Frontiers in Endocrinology|April 4, 2022
Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow UpJason Phowira, Katherine L Coffey, Peter H Bartholomew, et al.
Frontiers in Endocrinology|April 8, 2022
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer ImmunotherapyT Anders Olsen, Tony Zibo Zhuang, Sarah Caulfield, et al.
Frontiers in Endocrinology|April 25, 2022
Preclinical In Silico Evidence Indicates the Pharmacological Targets and Mechanisms of Mogroside V in Patients With Ovarian Cancer and Coronavirus Disease 2019Yongming Li, Yudong Chen, Mulan Wei, et al.
Pageof 1,951